Abstract 1558: Deciphering the role of ribosomal paralogs RPL39/RPL39L in metaplastic breast cancer
María F. Chervo(Houston Methodist), Jenny C. Chang(Universität Hamburg), Francesca Taraballi(Houston Methodist), Polina Matre(The University of Texas Health Science Center at Houston), Kristopher W. Brannan(Houston Methodist), Jianying Zhou(First Affiliated Hospital Zhejiang University), Liliana Guzman‐Rojas(Houston Methodist), Vrutant Shah(Houston Methodist), M Li(Houston Methodist), Chiara Mancino(Houston Methodist), Karina A. Ortega Martinez(Houston Methodist), Wei Qian(Houston Methodist)
Cited by 0
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies
|American Journal of Clinical Nutrition|1999|488